PharmaCyte Biotech, Inc. SEC filings PMCB
PharmaCyte Biotech, Inc. has 472 filings in SEC EDGAR's recent list, going back to Aug 20, 2001. Its latest annual report, Form 10-K, was filed on Jul 29, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (auditor change). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Sep 14, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Mar 17, 2026 | Jan 31, 2026 |
| 10-Q | Quarterly report | Dec 18, 2025 | Oct 31, 2025 |
| 10-Q | Quarterly report | Sep 15, 2025 | Jul 31, 2025 |
| 10-Q | Quarterly report | Mar 17, 2025 | Jan 31, 2025 |
| 10-Q | Quarterly report | Dec 13, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Sep 17, 2024 | Jul 31, 2024 |
| 10-Q | Quarterly report | Mar 18, 2024 | Jan 31, 2024 |
| 10-Q | Quarterly report | Dec 15, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Sep 18, 2023 | Jul 31, 2023 |
| 10-Q | Quarterly report | Mar 16, 2023 | Jan 31, 2023 |
| 10-Q | Quarterly report | Dec 14, 2022 | Oct 31, 2022 |
| 10-Q | Quarterly report | Sep 14, 2022 | Jul 31, 2022 |
| 10-Q | Quarterly report | Mar 15, 2022 | Jan 31, 2022 |
| 10-Q | Quarterly report | Dec 14, 2021 | Oct 31, 2021 |
| 10-Q | Quarterly report | Sep 14, 2021 | Jul 31, 2021 |
| 10-Q | Quarterly report | Mar 12, 2021 | Jan 31, 2021 |
| 10-Q | Quarterly report | Dec 11, 2020 | Oct 31, 2020 |
| 10-Q | Quarterly report | Sep 11, 2020 | Jul 31, 2020 |
| 10-Q | Quarterly report | Mar 13, 2020 | Jan 31, 2020 |
| 10-Q | Quarterly report | Dec 23, 2019 | Oct 31, 2019 |
| 10-Q | Quarterly report | Sep 13, 2019 | Jul 31, 2019 |
| 10-Q | Quarterly report | Mar 14, 2019 | Jan 31, 2019 |
| 10-Q | Quarterly report | Dec 14, 2018 | Oct 31, 2018 |
| 10-Q | Quarterly report | Sep 12, 2018 | Jul 31, 2018 |
| 10-Q | Quarterly report | Mar 19, 2018 | Jan 31, 2018 |
| 10-Q | Quarterly report | Dec 14, 2017 | Oct 31, 2017 |
| 10-Q | Quarterly report | Sep 13, 2017 | Jul 31, 2017 |
| 10-Q/A | Amended quarterly report | Mar 13, 2017 | Jan 31, 2017 |
| 10-Q | Quarterly report | Mar 13, 2017 | Jan 31, 2017 |
| 10-Q | Quarterly report | Dec 2, 2016 | Oct 31, 2016 |
| 10-Q | Quarterly report | Sep 6, 2016 | Jul 31, 2016 |
| 10-Q | Quarterly report | Mar 8, 2016 | Jan 31, 2016 |
| 10-Q/A | Amended quarterly report | Jan 19, 2016 | Oct 31, 2015 |
| 10-Q/A | Amended quarterly report | Jan 19, 2016 | Oct 31, 2015 |
| 10-Q/A | Amended quarterly report | Jan 19, 2016 | Jul 31, 2015 |
| 10-Q | Quarterly report | Dec 10, 2015 | Oct 31, 2015 |
| 10-Q | Quarterly report | Aug 25, 2015 | Jul 31, 2015 |
| 10-Q | Quarterly report | Mar 13, 2015 | Jan 31, 2015 |
| 10-Q | Quarterly report | Dec 15, 2014 | Oct 31, 2014 |
| 10-Q | Quarterly report | Sep 15, 2014 | Jul 31, 2014 |
| 10-Q | Quarterly report | Mar 17, 2014 | Jan 31, 2014 |
| 10-Q | Quarterly report | Dec 16, 2013 | Oct 31, 2013 |
| 10-Q | Quarterly report | Sep 16, 2013 | Jul 31, 2013 |
| 10-Q/A | Amended quarterly report | Apr 25, 2013 | Jul 31, 2011 |
| 10-Q | Quarterly report | Mar 26, 2013 | Jan 31, 2013 |
| 10-Q | Quarterly report | Dec 26, 2012 | Oct 31, 2012 |
| 10-Q | Quarterly report | Sep 19, 2012 | Jul 31, 2012 |
| 10-Q/A | Amended quarterly report | Mar 26, 2012 | Jul 31, 2011 |
| 10-Q | Quarterly report | Mar 21, 2012 | Jan 31, 2012 |
| 10-Q | Quarterly report | Dec 15, 2011 | Oct 31, 2011 |
| 10-Q/A | Amended quarterly report | Sep 20, 2011 | Jul 31, 2011 |
| 10-Q | Quarterly report | Sep 19, 2011 | Jul 31, 2011 |
| 10-Q/A | Amended quarterly report | Jun 8, 2011 | Oct 31, 2010 |
| 10-Q/A | Amended quarterly report | Jun 8, 2011 | Jul 31, 2010 |
| 10-Q/A | Amended quarterly report | Apr 26, 2011 | Oct 31, 2010 |
| 10-Q/A | Amended quarterly report | Apr 26, 2011 | Jul 31, 2010 |
| 10-Q | Quarterly report | Mar 8, 2011 | Jan 31, 2011 |
| 10-Q | Quarterly report | Jan 28, 2011 | Oct 31, 2010 |
| 10-Q | Quarterly report | Jan 14, 2011 | Jul 31, 2010 |
| 10-Q | Quarterly report | Mar 22, 2010 | Jan 31, 2010 |
| 10-Q | Quarterly report | Dec 21, 2009 | Oct 31, 2009 |
| 10-Q | Quarterly report | Sep 17, 2009 | Jul 31, 2009 |
| 10-Q | Quarterly report | Sep 14, 2009 | Apr 30, 2009 |
| 10-Q | Quarterly report | Mar 17, 2009 | Jan 31, 2009 |
| 10-Q | Quarterly report | Dec 12, 2008 | Oct 31, 2008 |
| 10-Q | Quarterly report | Sep 15, 2008 | Jul 31, 2008 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PMCB (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1157075
- Former names
- NUVILEX, INC. (until Jan 9, 2015); EFOODSAFETY COM INC (until Mar 17, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.